Medtech Companies to Watch: Galvanize Therapeutics Receives FDA Clearance for its INUMI Flex Endoscopic Needle

In a significant milestone in the medtech industry, Galvanize Therapeutics has received FDA clearance for its INUMI Flex Endoscopic Needle. This innovative device is a part of the Aliya pulsed electric field (PEF) portfolio, designed for soft tissue ablation. The FDA’s approval paves the way for enhanced treatment options in various medical fields, including cardiovascular, general surgery, lung, and aesthetics.

The INUMI Flex Endoscopic Needle represents a leap forward in the treatment of soft tissue conditions. Utilizing pulsed electric field technology, the device offers a minimally invasive approach to tissue ablation, aiming to reduce patient recovery time and improve procedural outcomes. This approval marks an essential step in expanding the use of PEF in clinical settings; a significant step in medtech innovation more broadly.

The device is designed to deliver precise and controlled electric pulses to targeted tissues, leading to effective ablation with minimal damage to surrounding areas. This precision is particularly beneficial in procedures requiring delicate handling of tissues, such as those in cardiovascular and lung surgeries.